GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (ASX:AGH) » Definitions » Notes Receivable

Althea Group Holdings (ASX:AGH) Notes Receivable : A$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Althea Group Holdings Notes Receivable?

Althea Group Holdings's Notes Receivable for the quarter that ended in Jun. 2024 was A$0.00 Mil.


Althea Group Holdings Notes Receivable Historical Data

The historical data trend for Althea Group Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Althea Group Holdings Notes Receivable Chart

Althea Group Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Notes Receivable
Get a 7-Day Free Trial - - - - -

Althea Group Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Althea Group Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Althea Group Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Althea Group Holdings Business Description

Traded in Other Exchanges
N/A
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into geographic segments: Australia, the United Kingdom, Canada, Germany and Ireland. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings Headlines